Family Office Of America (FOFA) Return on Capital Employed (2022 - 2026)
Family Office Of America recorded quarterly Return on Capital Employed of 11.01% in Q1 2026, up 86.64% quarter-over-quarter from 82.44% in Q4 2025, and up 6379.0% year-over-year from 0.17% in Q1 2025.
Family Office Of America's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 11.01% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 6379.0% year-over-year to 11.01%; the TTM figure through Mar 2026 stood at 11.01% (up 6379.0% YoY), while the FY2025 annual figure was 246.5%, down 54332.0% from the prior year.
- Return on Capital Employed came in at 11.01% for Q1 2026 at Family Office Of America, up from 82.44% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9444.54% in Q3 2024 to a low of 1725.4% in Q3 2023.
- A 5-year average of 558.74% and a median of 74.8% in 2025 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed soared 1116993 bps in 2024 and plunged 948651 bps in 2025, its largest moves.
- Family Office Of America's Return on Capital Employed stood at 303.98% in 2022, then surged by 116 bps to 49.71% in 2023, then jumped by 1775 bps to 932.12% in 2024, then sank by 109 bps to 82.44% in 2025, then surged by 87 bps to 11.01% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 11.01%, 82.44%, and 41.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Family Office Of America | - | - | 783,126.00 | -11.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.01% |
| Dec 31, 2025 | -82.44% |
| Sep 30, 2025 | -41.98% |
| Jun 30, 2025 | -46.42% |
| Mar 31, 2025 | -74.80% |
| Dec 31, 2024 | 932.12% |
| Sep 30, 2024 | 9,444.54% |
| Jun 30, 2024 | 3,339.63% |
| Mar 31, 2024 | -990.78% |
| Dec 31, 2023 | 49.71% |
| Sep 30, 2023 | -1,725.40% |
| Jun 30, 2023 | -1,409.50% |
| Mar 31, 2023 | -416.55% |
| Dec 31, 2022 | -303.98% |
| Sep 30, 2022 | -282.11% |